Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

ADRA1D receptor antagonist 1 HCl

Copy Product Info
😃Good
Catalog No. T10250Cas No. 1191908-14-1
Alias ADRA1D receptor antagonist 1 HCl(1191908-24-3 free base)

ADRA1D receptor antagonist 1 HCl is an orally active, potent and selective α1D adrenergic receptor antagonist (Ki: 1.6 nM) with potential antiproliferative activity.

ADRA1D receptor antagonist 1 HCl

ADRA1D receptor antagonist 1 HCl

Copy Product Info
😃Good
Purity: 98.13%
Catalog No. T10250Alias ADRA1D receptor antagonist 1 HCl(1191908-24-3 free base)Cas No. 1191908-14-1
ADRA1D receptor antagonist 1 HCl is an orally active, potent and selective α1D adrenergic receptor antagonist (Ki: 1.6 nM) with potential antiproliferative activity.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$1996-8 weeks6-8 weeks
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.13%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
ADRA1D receptor antagonist 1 HCl is an orally active, potent and selective α1D adrenergic receptor antagonist (Ki: 1.6 nM) with potential antiproliferative activity.
Targets&IC50
α1D-adrenoceptor:1.6 nM (Ki)
In vitro
ADRA1D receptor antagonist 1 exhibits low hERG inhibition and higher selectivity for α1D-AR over α1A- and α1B-ARs, without affecting α1A- and α1B-ARs[1].
In vivo
In the rat model of bladder outlet obstruction (BOO), ADRA1D receptor antagonist 1 (4.4 µg/kg; intravenous injection) dose-dependently decreased the occurrence of non-voiding bladder contractions during the urinary storage phase[1].
Animal Research
Animal Model: Rat with bladder outlet obstruction (BOO). Dosage: 4.4 μg/kg. Administration: Intravenous injection
SynonymsADRA1D receptor antagonist 1 HCl(1191908-24-3 free base)
Chemical Properties
Molecular Weight337.2
FormulaC15H14Cl2N4O
Cas No.1191908-14-1
SmilesCl.C[C@H](c1cccc(c1)C#N)n1cc(Cl)cc(C(N)=O)c1=N
Relative Density.no data available
Storage & Solubility Information
Storagekeep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (237.25 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.9656 mL14.8280 mL29.6560 mL148.2800 mL
5 mM0.5931 mL2.9656 mL5.9312 mL29.6560 mL
10 mM0.2966 mL1.4828 mL2.9656 mL14.8280 mL
20 mM0.1483 mL0.7414 mL1.4828 mL7.4140 mL
50 mM0.0593 mL0.2966 mL0.5931 mL2.9656 mL
100 mM0.0297 mL0.1483 mL0.2966 mL1.4828 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy ADRA1D receptor antagonist 1 HCl | purchase ADRA1D receptor antagonist 1 HCl | ADRA1D receptor antagonist 1 HCl cost | order ADRA1D receptor antagonist 1 HCl | ADRA1D receptor antagonist 1 HCl chemical structure | ADRA1D receptor antagonist 1 HCl in vivo | ADRA1D receptor antagonist 1 HCl in vitro | ADRA1D receptor antagonist 1 HCl formula | ADRA1D receptor antagonist 1 HCl molecular weight